PRME CIK: 1894562

Prime Medicine, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
271
FY22:
297
FY23:
143
FY24:
212
FY25:
181
(positive)
Change from FY21 to FY25
millions USD
FY21:
31.3
FY22:
63.7
FY23:
50.9
FY24:
85.6
FY25:
161
Total assets
Change from FY21 to FY25
millions USD
FY21:
302
FY22:
360
FY23:
194
FY24:
298
FY25:
343

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
58.0
FY22:
26.7
FY23:
56.4
FY24:
38.0
FY25:
37.4
(negative)
Change from FY21 to FY25
millions USD
FY21:
4.31
FY22:
17.3
FY23:
4.36
FY24:
106
FY25:
184
(positive)
Change from FY21 to FY25
millions USD
FY21:
−156
FY22:
316
FY23:
133
FY24:
153
FY25:
121
Total liabilities & equity
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
360
FY23:
194
FY24:
298
FY25:
343

All amounts in millions USD Data source:SEC EDGAR